Symbol="INMB"
AssetType="Common Stock"
Name="INmune Bio Inc"
Description="INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer, Alzheimer's disease, and nonalcoholic steatohepatitis. The company is headquartered in La Jolla, California."
CIK="1711754"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="1200 PROSPECT STREET, SUITE 525, LA JOLLA, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="141110000"
EBITDA="None"
PERatio="None"
PEGRatio="None"
BookValue="2.823"
DividendPerShare="0"
DividendYield="0"
EPS="-1.5"
RevenuePerShareTTM="0.016"
ProfitMargin="0"
OperatingMarginTTM="-92.58"
ReturnOnAssetsTTM="-0.205"
ReturnOnEquityTTM="-0.441"
RevenueTTM="279000"
GrossProfitTTM="374000"
DilutedEPSTTM="-1.5"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.875"
AnalystTargetPrice="17.33"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="306.31"
PriceToBookRatio="2.155"
EVToRevenue="216.5"
EVToEBITDA="-3.247"
Beta="1.944"
num_52WeekHigh="11.26"
num_52WeekLow="5.75"
num_50DayMovingAverage="8.89"
num_200DayMovingAverage="8.0"
SharesOutstanding="18021700"
DividendDate="None"
ExDividendDate="None"
symbol="INMB"
open="7.69"
high="8.00"
low="7.59"
price="7.83"
volume="12742.00"
latest_trading_day="2023-08-21"
previous_close="7.71"
change="0.12"
change_percent="1.5564%"
aroon_positive_momentum_days="57"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="57"
Volume_recent_avg="56958"
Change_recent_avg="-0.01"
Delta_recent_avg="0.58"
Variance_recent_avg="0.29"
Change_ratio_recent_avg="-0.19"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="57"
Aroon_momentum_negative="43"
image_negative_thumbnail_id_1="514"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0091.jpeg"
image_negative_thumbnail_id_2="101"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0075.jpeg"
image_neutral_thumbnail_id_1="536"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0063.jpeg"
image_neutral_thumbnail_id_2="551"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0048.jpeg"
image_positive_thumbnail_id_1="636"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0072.jpeg"
image_positive_thumbnail_id_2="627"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0081.jpeg"
image_professor_thumbnail_id_1="1174"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
image_professor_thumbnail_id_2="1188"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
